KAPIDEX(TM) (dexlansoprazole) delayed release capsules Now Available for the Treatme... ( DEERFIELD Ill. Feb. 23 /- Takeda Phar...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

KAPIDEX(TM) (dexlansoprazole) delayed release capsules Now Available for the Treatment of GERD

Date:2/23/2009

DEERFIELD, Ill., Feb. 23 /PRNewswire/ -- Takeda Pharmaceuticals North America, Inc. today announced that KAPIDEX(TM) (dexlansoprazole) delayed release capsules are now available in pharmacies across the U.S. KAPIDEX, available in 30 mg and 60 mg doses, was recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of heartburn associated with symptomatic non-erosive Gastroesophageal Reflux Disease (GERD), the healing of erosive esophagitis (EE) and the maintenance of healed EE.

KAPIDEX is the first proton pump inhibitor (PPI) with a Dual Delayed Release(TM) (DDR) formulation designed to provide two separate releases of medication. PPIs work by turning off many of the acid pumps in the stomach. KAPIDEX contains two types of enteric-coated granules resulting in a concentration-time profile with two distinct peaks: the first peak occurs one to two hours after administration, followed by a second peak within four to five hours. In addition, KAPIDEX can be taken regardless of when food is consumed.

GERD is a chronic condition commonly known as acid reflux disease. GERD affects nearly 19 million Americans and is often characterized by frequent and persistent heartburn that occurs two or more days a week despite treatment and diet changes. GERD can affect both men and women, and symptoms are often triggered by certain foods, stress or pressure on the stomach.

About KAPIDEX (dexlansoprazole) delayed release capsules

KAPIDEX (dexlansoprazole) delayed release capsules, previously known by the development code TAK-390MR, is a proton pump inhibitor (PPI), which decreases acid production by turning off many of the acid pumps in the stomach, thus helping to protect the esophagus from acidic reflux so that esophageal inflammation can heal. KAPIDEX combines an enantiomer of lansoprazole with a Dual Delayed Release(TM) (DDR) formulation designed to provide two separ
'/>"/>

SOURCE Takeda Pharmaceuticals North America, Inc.
Copyright©2009 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2 3
Related medicine news :

1. KV Pharmaceuticals Launch of Gestiva(TM) Delayed
2. Mylan Receives Final FDA Approval for Generic Version of Prilosec(R) Delayed-Release Capsules, 40 mg
3. SEIU Decision to Force Transfer of Long-Term Care Members Out of United Healthcare Workers Delayed
4. Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R)
5. Heart Attack Care Often Delayed for the Poor
6. Womens Alcohol Use Tied to Delayed Childbearing
7. Lupin Receives USFDA Approval for Divalproex Sodium Delayed-Release Tablets
8. Caraco Pharmaceutical Laboratories, Ltd. to Market Generic Depakote(R) Delayed Release Tablets
9. Watson Launches Omeprazole Delayed-Release Capsules, 40MG
10. Delayed Sleep Pattern Tied to Irregular Menstrual Cycles
11. Teens Sleep Longer With Delayed School Starts

Post Your Comments:

(Date:5/23/2013)... FL (PRWEB) May 23, 2013 ... regenerative medicine company focused on the commercialization of ... and regeneration, today announced that the Company and ... million grant, for which AxoGen’s portion is approximately ... administrated by the U.S. Department of Defense (DoD) ...

(Date:5/23/2013)... 2013 Hile Design LLC is pleased ... awarded a Silver Creative Award at the Summit International ... entry was for its “Open Doors” animation promoting Scio ... in the 2013 District 6 ADDY Awards for the ... Creative Award recognizes and celebrates the creative achievements of ...

(Date:5/23/2013)... Utah (PRWEB) May 23, 2013 Registered ... R.D., published an article today on Tatalou.com offering helpful ... vacation. , The article, titled “ How to Stay ... important to carry hand sanitizer, when it’s safe to ... out for seafood, the importance of staying hydrated and ...

(Date:5/23/2013)... OH and Durham, NC (PRWEB) May 23, 2013 ... and commercialization firm that funds and develops innovative ... Deep Brain Innovations, LLC (DBI). DBI will ... optimize deep brain stimulation (DBS) therapy for patients ... is effective in treating Parkinson’s disease and generates ...

(Date:5/23/2013)... Consortium, Ltd., issued the following statement today on ... Reform of chemical safety legislation will succeed only ... Ensuring the safety and appropriate use of chemicals ... Toxic Substances Control Act is a critical opportunity ... transforming toxicity testing "from a system based on ...

Breaking Medicine News(10 mins):Health News:AxoGen, Inc. Receives Grant in Partnership with Vanderbilt University from U.S. Department of Defense 2 Health News:AxoGen, Inc. Receives Grant in Partnership with Vanderbilt University from U.S. Department of Defense 3 Health News:How to Stay Healthy While Traveling 2 Health News:NDI Launches Deep Brain Innovations, LLC 2 Health News:NDI Launches Deep Brain Innovations, LLC 3

[0] AxoGen, Inc. Receives Grant in Partnership with Vanderbilt University from U.S. Department of Defense [0] Hile Design Wins Silver Creative Award at the 2013 Summit Internationals [0] How to Stay Healthy While Traveling [0] NDI Launches Deep Brain Innovations, LLC [0] Chemical Safety Improvement Act of 2013: PETA International Science Consortium

... global research,organization, announced that it has appointed new staff ... Resourcing Solutions,division. Maria Sanchez Garcia will lead the group ... whilst Hannah King joins our United,Kingdom team to focus ... very pleased to help in the continued growth of ...

... deal demonstrates commitment to dermatology and innovation, ... Stiefel Laboratories, Inc.,the world,s largest independent pharmaceutical ... has completed its previously announced,acquisition of Princeton, ... of the acquisition, all remaining outstanding shares ...

... Call and Webcast Scheduled for August 7, 2008 ... Aug. 6 The Ensign,Group, Inc. (Nasdaq: ... group of,skilled nursing, rehabilitative care services and assisted ... quarter of fiscal,year 2008., (Logo: http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO ...

... ... Diluted FAD ... Second Quarter Investments $250 Million, NEWPORT BEACH, Calif., ... operations,and investment activity for the second quarter and the six months ended,June 30, 2008., ...

... put themselves at increased risk for second malignancies , , ... British adults who survived childhood cancers currently smoke, while ... in their lives, a new study reports. , ... cancer have a greater chance of developing cardiovascular disease, ...

... Aug. 6 AMN Healthcare Services,Inc. (NYSE: AHS ... leader in all of its business segments today reported ... quarter last year and a 7%,increase from last quarter. ... Nurse & Allied, Locum Tenens and,Physician Permanent Placement, experienced ...

Chiltern's Resourcing Solutions Division Appoints New Managers to Spain and the United Kingdom Stiefel Laboratories Completes Acquisition of Barrier Therapeutics The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance NHP Reports Second Quarter 2008 Earnings One-Fifth of British Childhood Cancer Survivors Smoke AMN Healthcare Reports Second Quarter 2008 Results

(Date:5/23/2013)... BioElectronics Corporation (OTC Pink: BIEL), the maker of ... FDA panel meeting for non-thermal shortwave diathermy: ... Therapy Meeting was held on May 21, 2013 in ... of the meeting was very narrow, in that the ... the application of non-thermal shortwave diathermy for the treatment ...

(Date:5/23/2013)... Conn. , May 23, 2013 CAS Medical Systems, ... medical devices for non-invasive patient monitoring, today announced that ... Officer, will present at the 2 nd Annual Marcum ... Hyatt Hotel in New York City . ... p.m. ET in the Estate 10 room and will be ...

(Date:5/23/2013)... , May 23, 2013 Halozyme ... announced the appointment of David A. ... Ramsay was most recently Vice President, Corporate Development ... ) "With his established financial management ... gained by working in our commercial group for ...

Breaking Medicine Technology:BioElectronics and Pulsed Shortwave Therapy Make Progress 2 CASMED to Present at the 2nd Annual Marcum MicroCap Conference 2 Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer 2

[0] BioElectronics and Pulsed Shortwave Therapy Make Progress [0] CASMED to Present at the 2nd Annual Marcum MicroCap Conference [0] Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer

... May 21 Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader ... Citi Investment Research,s 2010 Global Health Care Conference on Thursday, May 27, ... Hotel. , , , ... the presentation will be available on the "Investors & Media" section of the ...

... Sorrento Therapeutics, Inc. (OTC Bulletin Board: SRNE) ... Small Business Technology Transfer Research (STTR) grant from the ... grant was awarded to support the Company,s program to ... combat Staphylococcus aureus ( S. aureus ...

Cached Medicine Technology:Isis Pharmaceuticals to Present at the 2010 Citi Investment Research Global Health Care Conference 2 Sorrento Therapeutics Awarded NIH Grant for MRSA Program 2 Sorrento Therapeutics Awarded NIH Grant for MRSA Program 3 Sorrento Therapeutics Awarded NIH Grant for MRSA Program 4

Isis Pharmaceuticals to Present at the 2010 Citi Investment Research Global Health Care Conference Sorrento Therapeutics Awarded NIH Grant for MRSA Program

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

Medicine Products:

Lyme Antibodies, Total (CSF)Luteinizing Hormone, Pooled Lupus Anticoagulant Panel with Reflex to 1:1 Mixes & Confirmations Lupus Erythematous, Tissue